12 insiders reported 45 Form 4 transactions for AN2 Therapeutics, Inc. (ANTX) over the past 18 months (most recent 2026-06-02). Recent activity: Williams Sarah Joanne (Principal Accounting Officer) Sell 265 shares, Aziz Kabeer (Director) Buy 3,775 shares, Martin Patricia A. (Director) Buy 1,192 shares, Marks Gilbert Lynn (Director) Buy 3,775 shares, Williams Sarah Joanne (Principal Accounting Officer) Sell 327 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-02 | Williams Sarah Joanne | Principal Accounting Officer | Sell | 265 | $1,174 |
| 2026-04-10 | Aziz Kabeer | Director | Buy | 3,775 | $0 |
| 2026-04-10 | Martin Patricia A. | Director | Buy | 1,192 | $0 |
| 2026-04-10 | Marks Gilbert Lynn | Director | Buy | 3,775 | $0 |
| 2026-03-05 | Williams Sarah Joanne | Principal Accounting Officer | Sell | 327 | $347 |
| 2026-02-23 | Chanda Sanjay | Chief Development Officer | Buy | 38,000 | $0 |
| 2026-02-23 | Day Lucy | Chief Financial Officer | Buy | 38,000 | $0 |
| 2026-02-23 | Williams Sarah Joanne | Principal Accounting Officer | Buy | 48,375 | $0 |
| 2026-02-23 | Easom Eric | Chief Executive Officer | Buy | 112,250 | $0 |
| 2026-02-23 | Eizen Joshua M | See Remarks | Buy | 50,000 | $0 |
| 2026-01-14 | Marks Gilbert Lynn | Director | Buy | 11,560 | $0 |
| 2026-01-14 | Aziz Kabeer | Director | Buy | 11,560 | $0 |
| 2026-01-14 | Martin Patricia A. | Director | Buy | 3,650 | $0 |
| 2026-01-07 | Day Lucy | Chief Financial Officer | Sell | 3,295 | $3,295 |
| 2026-01-07 | Day Lucy | Chief Financial Officer | Sell | 5,512 | $5,567 |
| 2026-01-07 | Eizen Joshua M | See Remarks | Sell | 17,923 | $17,923 |
| 2026-01-07 | Eizen Joshua M | See Remarks | Sell | 6,931 | $7,000 |
| 2026-01-07 | Prior Stephen David | Chief Strategy Officer | Sell | 3,604 | $3,604 |
| 2026-01-07 | Prior Stephen David | Chief Strategy Officer | Sell | 2,858 | $2,887 |
| 2026-01-07 | Chanda Sanjay | Chief Development Officer | Sell | 3,295 | $3,295 |
| 2026-01-07 | Chanda Sanjay | Chief Development Officer | Sell | 5,956 | $6,016 |
| 2025-11-06 | Prior Stephen David | Chief Strategy Officer | Sell | 765 | $872 |
| 2025-11-06 | Eizen Joshua M | See Remarks | Sell | 2,819 | $3,214 |
| 2025-10-14 | Marks Gilbert Lynn | Director | Buy | 10,367 | $0 |
| 2025-10-14 | Aziz Kabeer | Director | Buy | 10,367 | $0 |
Source: SEC Form 4 filings · as of 2026-06-02